Fig. 1From: Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disordersThe neuroprotective effects of osteocalcin (OCN) in rats with Parkinson’s disease (PD). OCN, administered either peripherally or centrally, ameliorates motor dysfunction, reduces dopaminergic neuronal loss and diminishes glia-mediated inflammatory responses in PD rat model induced by 6-OHDA via the AKT/GSK3β signaling pathwayBack to article page